Lorella Tripodi

Ceinge Biotecnologie Avanzate (Italy)

Papers

1

Total Citations

47

H-Index

1

About

Lorella Tripodi is a leading researcher in the fields of urological oncology and oxidative stress biomarkers, with a particular focus on prostate cancer (PCa). Her major contributions center on elucidating the molecular mechanisms of disease through the measurement of urinary biomarkers, specifically 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-iso-prostaglandin F2α (8-IsoF2α). In her most-cited work (2022, 47 citations), she demonstrated how these markers can assess oxidative stress damage following robot-assisted radical prostatectomy (RARP), providing critical insights into post-surgical tissue injury and recovery. This research has significant implications for refining diagnostic panels and improving patient monitoring in PCa management. Tripodi’s work bridges the gap between basic oxidative stress biology and clinical application, offering potential for non-invasive disease assessment. Her findings are highly cited, reflecting their impact on both the scientific community and clinical practice. By advancing the understanding of how oxidative stress contributes to cancer progression and surgical outcomes, Tripodi continues to shape the future of personalized medicine in urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
47 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Ceinge Biotecnologie Avanzate (Italy)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago